Press Release
November 17, 2026

Empower Oversight asks Congress to intervene after two new investigations target the special agents who came forward

WASHINGTON – Empower Oversight sent a letter asking congressional leaders to use their oversight authority over the Drug Enforcement Administration (DEA) to protect whistleblowers and end the serious, illegal retaliation against two DEA special agents. The agents exposed the DEA’s “policy” of allowing fentanyl to move throughout New Mexico without being interdicted—in some cases with children around a drug so deadly that, in the DEA’s own words, “One Pill Can Kill.”

Special Agents David Howell and Emmett Fritz made protected whistleblower disclosures to the Department of Justice (DOJ) Office of the Inspector General (OIG). They reported that the DEA and the U.S. Attorney’s Office for the District of New Mexico (USAO-NM) were intentionally failing to seize known fentanyl shipments, a practice known as “walking.”

“The public pressure generated by these whistleblower disclosures has pushed the DEA’s retaliation to dangerous new levels, recently prompting not one but two retaliatory investigations of our clients,” said Empower Oversight President Tristan Leavitt. “These investigations are outrageous. We need Congress’s help to make clear to the DEA that this retaliation is unacceptable and must stop immediately.”

The two new investigations follow months of retaliation that began when the fentanyl walking allegations became public on June 21, 2026. Even before the stories ran, Assistant Special Agent in Charge (ASAC) Jeffrey Armijo, the highest-ranking official in the DEA’s Albuquerque District Office, asked SA Howell whether he had spoken to the media. After they ran, ASAC Armijo told longtime DEA contractor Kevin Small, “If you support David Howell, we’re through.” Mr. Small was stripped of his duties and ultimately forced to resign.

Since then, SA Howell and SA Fritz have been ostracized in the office, denied training and travel, and excluded from operations. Their appraisals have been repeatedly rejected and delayed, and they have been encouraged to retire.

The latest acts of retaliation are:

  • An internal affairs investigation of SA Fritz. Shortly after the Office of Special Counsel (OSC) interviewed SA Fritz about a retaliation complaint naming Group Supervisor (GS) Billy Baker, DEA internal affairs opened an investigation into documents SA Fritz had given to OSC: DEA policies that were being used against him as part of the retaliation. SA Fritz sent those policies to his attorneys and to OSC from his personal email account in support of his whistleblower retaliation complaint. They are the same policies that the New Mexico congressional delegation and House Oversight Chairman James Comer have requested from the DEA.
  • An OIG “leak” investigation. Two days after SA Howell gave his first on-camera interview, DOJ OIG investigators arrived in Albuquerque to look into an alleged “leak” of “operational information.” The reporter who asked the DEA about it identified the Albuquerque Police Department—not Empower Oversight’s clients—as her source. Even so, the investigation was perceived as retaliatory and appears to have chilled current whistleblowers in the Albuquerque office.

SA Howell and SA Fritz came forward with information about fentanyl walking that they reasonably believed violated DEA and DOJ policy and posed a substantial and specific danger to public health and safety. The public response has confirmed how serious the situation is. Their disclosures are protected by federal whistleblower protection laws and by the laws safeguarding communications with Congress.

As Leavitt writes in the letter: “In black and white, those laws are robust. In practice, they too often require vigorous oversight pushing back on inappropriate agency action in order to actually expose and deter agency misconduct.

“But it is extremely difficult to expect federal employees to step forward if they are not actually protected against retribution and reprisal.”

Read the full letter here.

###